this post was submitted on 06 Jul 2023
32 points (100.0% liked)

News

327 readers
1 users here now

Breaking news and current events worldwide.

founded 1 year ago
 

The first approved drug to slow the progression of the illness will come with a strong safety warning about potentially life-threatening side effects.

top 3 comments
sorted by: hot top controversial new old
[–] [email protected] 5 points 1 year ago

I was all excited until the blurb about life threatening side effects:(

Obviously this is still a good step forward, but if it works, I wonder if they can use that knowledge to lessen the risk of death...

[–] agentshags 2 points 1 year ago

Leqembi, from Japanese drugmaker Eisai and U.S.-based drugmaker Biogen, targets a type of protein in the brain called beta-amyloid, long thought by scientists to be one of the underlying causes of Alzheimer’s disease.

[–] grizzledgrizzly 2 points 1 year ago

Biologics are the medication therapy of the future. We just need to be able to get them accessible for patients.